Westover Capital Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.67M | Buy |
15,086
+8,199
| +119% | +$909K | 0.33% | 65 |
|
|
2025
Q1 | $772K | Buy |
+6,887
| New | +$772K | 0.17% | 110 |
|
|
2024
Q1 | – | Sell |
-3,779
| Closed | -$306K | – | 195 |
|
|
2023
Q4 | $306K | Buy |
3,779
+19
| +0.5% | +$1.54K | 0.1% | 139 |
|
|
2023
Q3 | $282K | Hold |
3,760
| – | – | 0.1% | 141 |
|
|
2023
Q2 | $290K | Buy |
+3,760
| New | +$290K | 0.1% | 145 |
|
|
2020
Q4 | – | Sell |
-7,699
| Closed | -$486K | – | 155 |
|
|
2020
Q3 | $486K | Sell |
7,699
-1,740
| -18% | -$110K | 0.2% | 89 |
|
|
2020
Q2 | $726K | Buy |
9,439
+6,066
| +180% | +$467K | 0.34% | 73 |
|
|
2020
Q1 | $252K | Buy |
+3,373
| New | +$252K | 0.14% | 99 |
|
|
2017
Q2 | – | Sell |
-5,563
| Closed | -$378K | – | 113 |
|
|
2017
Q1 | $378K | Buy |
5,563
+46
| +0.8% | +$3.13K | 0.25% | 81 |
|
|
2016
Q4 | $395K | Sell |
5,517
-7,968
| -59% | -$570K | 0.28% | 75 |
|
|
2016
Q3 | $1.07M | Sell |
13,485
-1,484
| -10% | -$117K | 0.79% | 42 |
|
|
2016
Q2 | $1.25M | Buy |
14,969
+2,314
| +18% | +$193K | 1.02% | 36 |
|
|
2016
Q1 | $1.16M | Buy |
12,655
+1,699
| +16% | +$156K | 0.98% | 36 |
|
|
2015
Q4 | $1.11M | Buy |
10,956
+1,327
| +14% | +$134K | 0.92% | 39 |
|
|
2015
Q3 | $945K | Sell |
9,629
-17
| -0.2% | -$1.67K | 0.81% | 41 |
|
|
2015
Q2 | $1.13M | Buy |
9,646
+1,155
| +14% | +$135K | 0.9% | 38 |
|
|
2015
Q1 | $833K | Buy |
+8,491
| New | +$833K | 0.67% | 49 |
|
|
2014
Q4 | – | Sell |
-1,954
| Closed | -$208K | – | 87 |
|
|
2014
Q3 | $208K | Buy |
+1,954
| New | +$208K | 0.17% | 87 |
|